Newsfeeds - Spark Newswire

4 minute read

FDA
News

Medtronic Continuous Glucose Monitoring To Be Reimbursed For Eligible Alberta Youth Living With Diabetes

Today, 4:58 AM

Medtronic continuous glucose monitoring to be reimbursed for eligible Alberta youth living with diabetes New government program enables access to integrated hybrid closed loop technology for 18 and under BRAMPTON,

MDT

1 minute read

Needham Maintains Buy on Medtronic, Lowers Price Target to $128

By Benzinga Newsdesk

Today, 4:58 AM

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $131 to $128.

MDT

3 minute read

FDA
News

Medtronic Announces FDA Approval Of Spinal Cord Stimulation Therapy For Treating Chronic Pain Resulting From Diabetic Peripheral Neuropathy

By Benzinga Newsdesk

Today, 4:58 AM

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration approval of its Intellis™ rechargeable neurostimulator and Vanta™

MDT

2 minute read

Medtronic Recalls HawkOne Atherectomy System Due To Tip Damage Risk

By Vandana Singh

Today, 4:58 AM

Medtronic Inc (NYSE: MDT) is recalling HawkOne Directional Atherectomy System due to the risk of the guidewire within the

MDT

1 minute read

10 Biggest Price Target Changes For Friday

By Lisa Levin

Today, 4:58 AM

Barclays cut Netflix, Inc. (NASDAQ: NFLX) price target from $675 to $425. Netflix shares fell 19.6% to $408.58 in pre-market trading.

CMG

1 minute read

SVB Leerink Maintains Market Perform on Medtronic, Lowers Price Target to $115

By Benzinga Newsdesk

Today, 4:58 AM

SVB Leerink analyst Danielle Antalffy maintains Medtronic (NYSE:MDT) with a Market Perform and lowers the price target from $138 to $115.

MDT

1 minute read

Citigroup Maintains Buy on Medtronic, Lowers Price Target to $129

By Benzinga Newsdesk

Today, 4:58 AM

Citigroup maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $130 to $129.

MDT

1 minute read

Medtronic’s Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief

By Vandana Singh

Today, 4:58 AM

Medtronic plc (NYSE: MDT)

MDT

2 minute read

FDA
News

Medtronic Announces Results Showing Meaningful Pain Relief Using DTM Spinal Cord Stimulation Endurance Therapy

By Benzinga Newsdesk

Today, 4:58 AM

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective, multi-center study1 showing meaningful pain relief using DTM™ SCS

MDT